Search For "sgl"
SGL Labs expands Global Presence with grand opening of International Diamo
Updated : 2 years, 10 months ago IST
New Delhi [India], May 29: SGL Labs, the world's largest privately owned diamond certification lab with headquarters in London and New York, proudly announces the grand opening of its 16th lab in India, located in the vibrant city of Lucknow. This new international diamond certification l
Read More
Daewoong Pharmaceutical announce Publication of Phase 3 Study of 'Envlo',
Updated : 2 years, 11 months ago IST
Seoul [South Korea], April 24 (ANI/PRNewswire): The research results of Daewoong Pharmaceutical's SGLT-2 inhibitor new drug, 'Envlo', have been internationally acknowledged.
Read More
The 17th annual FURA Retail Jeweller India Awards 2022 recognizes excellen
Updated : 3 years, 7 months ago IST
Mumbai (Maharashtra) [India], August 9 (ANI/NewsVoir): After a COVID-break of two consecutive years, the 17th edition of FURA Retail Jeweller India Awards 2022 (RJIA), recognized as the Oscars of India's retail jewellery industry, in association with Solitaire Gemological Laboratories (SGL),
Read More
New study challenges previous link between diabetes medication and fractur
Updated : 3 years, 10 months ago IST
Washington [US], May 27 (ANI): Sodium-glucose transporter-2 (SGLT2) inhibitors, which reduce renal glucose reabsorption, may help control blood sugar and protect kidney health in patients with diabetic renal failure; however, several large clinical trials have linked these drugs to a higher
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i
Read More
Glenmark Pharmaceuticals launches fixed-drug combination for management of
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra) [India], December 29 . (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination (FDC) of its novel, patent protected and globally researched Sodium Glucose Co-Transporter Inhibitor (
Read More
Newer Type 2 diabetes medications have heart and kidney disease benefits,
Updated : 5 years, 6 months ago IST
Washington [US], September 28 (ANI): Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
Read More